March 16, 2026 · Form 4 insider transaction
Grossman Adam S sold 15,000 shares of ADMA Biologics, Inc. at $15.16 per share, a transaction worth $227.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Transaction was effected pursuant to a Rule 10b5-1 trading plan entered into between the Reporting Person and Fidelity Brokerage Services LLC on November 14, 2025.; The price reported in Column 4 is the price at which the shares were sold.